Navigation Links
Spherix Announces Third Quarter Financial Results
Date:11/11/2011

017,072LIABILITIES AND STOCKHOLDERS' EQUITYCurrent liabilitiesAccounts payable and accrued expenses

$
250,383$
,211,561Accrued salaries and benefits

432,052563,706Deferred revenue

68,442170,641Total current liabilities

750,8771,945,908Deferred compensation

-550,000Deferred rent

56,27680,945Total liabilities

807,1532,576,853Commitments and contingencies

--Stockholders' equityPreferred stock, $0.01 par value, 2,000,000 shares authorized;5,250 series B issued and 1 outstanding at September 30, 2011and December 31, 2010

--Common stock, $0.01 par value, 5,000,000 shares authorized; 2,570,531 and 2,143,631 issued, 2,562,488 and 2,135,588outstanding at September 30, 2011 and December 31, 2010,respectively

25,70521,436Paid-in capital in excess of par value

41,109,89438,568,814Treasury stock, 8,043 shares, at cost at September 30, 2011and December 31, 2010

(464,786)(464,786)Accumulated deficit

(35,847,638)(33,685,245)Total stockholders' equity

4,823,1754,440,219Total liabilities and stockholders' equity

$
5,630,328$
7,017,072
'/>"/>

SOURCE Spherix Incorporated
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Spherix Announces Closing of Private Placement of $1.25 Million, Discusses Use of Proceeds
2. Spherix to Raise $1.25 Million in Private Placement
3. Spherix Announces Results from New Preclinical Studies Showing SPX-106T Produces Significant Reductions in Cholesterol, Fat Deposition and Body Weight
4. Spherix Announces Annual Shareholders Meeting Date
5. Spherix to Present at the 5th Lippert/Heilshorn Life Sciences & Medical Technologies Virtual Conference on June 16
6. Spherix Regains Compliance With NASDAQ Listing Rule
7. Spherix Announces First Quarter Financial Results
8. Spherix Announces Reverse Stock Split Effective May 6, 2011
9. Spherix to Effect Reverse Stock Split
10. Spherix Announces 2010 Financial Results
11. Spherix to Present at the BIO-Windhover/Pharmaceutical Strategic Outlook 2011 Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... PARK, Calif. , July 24, 2014 /PRNewswire/ ... company in the emerging field of regenerative medicine, ... webcast of a presentation to investors on Tuesday, ... p.m. PDT.  The presentation will include an overview ... To access the webcast, visit http://www.ustream.tv/channel/asterias-biotherapeutics ...
(Date:7/24/2014)... of Engineering at the University of Delaware, is ... in energy engineering, environmental sustainability and electronics. , ... rock with a well-defined, crystalline structure. At the ... decided that zeolites can separate molecules with size ... (one-tenth of a nanometer), making them useful to ...
(Date:7/24/2014)... 24, 2014 SRI International has been awarded ... Institute of Allergy and Infectious Diseases (NIAID), part of ... of potential therapies for HIV infection and AIDS. The ... and AIDS and the complications and opportunistic infections associated ... sexual transmission of HIV. According to ...
(Date:7/24/2014)... July 24, 2014 WIRB-Copernicus Group ® ... and ethical review services for clinical research, announced ... a division of Richmond, VA ... biosafety and biosecurity consulting firm in ... WCG,s biosafety division – WCG Biosafety™ – will ...
Breaking Biology Technology:Asterias Biotherapeutics Announces Live Investor Webcast 2Asterias Biotherapeutics Announces Live Investor Webcast 3Asterias Biotherapeutics Announces Live Investor Webcast 4University of Delaware researcher describes new approach for creating organic zeolites 2National Institute of Allergy and Infectious Diseases Awards SRI International Contract to Study New Therapies for HIV and AIDS 2National Institute of Allergy and Infectious Diseases Awards SRI International Contract to Study New Therapies for HIV and AIDS 3WIRB-Copernicus Group Announces Acquisition of Alliance Biosciences; Executives Join WCG Biosafety Division 2WIRB-Copernicus Group Announces Acquisition of Alliance Biosciences; Executives Join WCG Biosafety Division 3
... Bernd Eschweiler and Beate Kilb, Institute for Water Research, Schwerte, Germany , ... Introduction , Bacterial diversity in environmental ... of isolated strains. A problem for the analysis and , ... most of the bacteria species present in the sample. Therefore isolated ...
... , Tochigi Cancer Center, Tochigi, Japan , ... Introduction , Denaturing gradient gel electrophoresis (DGGE) ... scanning methods. It has evolved enormously over the last , ... A practical method on this topic has been reported recently. 1 The ...
... Ibrahim Buyuksal, and William S. Dalton,H. Lee Moffitt Cancer Center and Research Institute, ... , ... Identifying of mutations within specific genes has become an important , ... many diseases, , including cancer. Several ...
Cached Biology Technology:Microbial Diversity in Ground and Surface Water Analyzed by Denaturing Gradient Gel Electrophoresis Using the DCode System 2Microbial Diversity in Ground and Surface Water Analyzed by Denaturing Gradient Gel Electrophoresis Using the DCode System 3Microbial Diversity in Ground and Surface Water Analyzed by Denaturing Gradient Gel Electrophoresis Using the DCode System 4Detection of p53 Gene in Breast Cancer by Denaturing Gradient Gel Electrophoresis and the DCode System 2Detection of p53 Gene in Breast Cancer by Denaturing Gradient Gel Electrophoresis and the DCode System 3Detection of Mutations in the Fas Antigen of Lymphoma Tumors by RT-PCR and Denaturing Gradient Gel Electrophoresis 2Detection of Mutations in the Fas Antigen of Lymphoma Tumors by RT-PCR and Denaturing Gradient Gel Electrophoresis 3Detection of Mutations in the Fas Antigen of Lymphoma Tumors by RT-PCR and Denaturing Gradient Gel Electrophoresis 4Detection of Mutations in the Fas Antigen of Lymphoma Tumors by RT-PCR and Denaturing Gradient Gel Electrophoresis 5
(Date:7/25/2014)... 1 (NRG1) is a pleiotropic factor characterized by ... splicing of exons that confer to the protein ... for both the myelination occurring during development and ... peripheral nerve: axon degeneration, axon regrowth, remyelination and ... Australia have discovered that the soluble NRG1 upregulation ...
(Date:7/25/2014)... a molecular testing panel developed at UPMC greatly ... surgery for patients with thyroid nodules and cancer, ... Institute (UPCI), partner with UPMC CancerCenter., The test, ... other diagnostic testing agencies, improved the chances of ... percent, according to the study published this month ...
(Date:7/24/2014)... York, NY - July 24, 2014 -- Keryx Biopharmaceuticals, ... from the long-term, randomized, active control Phase 3 study ... iron-based phosphate binder, for the treatment of hyperphosphatemia in ... PERFECTED study (PhosphatE binding and iRon delivery with FErric ... Journal of the American Society of Nephrology ...
Breaking Biology News(10 mins):Test increases odds of correct surgery for thyroid cancer patients 2Test increases odds of correct surgery for thyroid cancer patients 3Zerenex™ (ferric citrate) long-term Phase 3 study results published in JASN 2Zerenex™ (ferric citrate) long-term Phase 3 study results published in JASN 3Zerenex™ (ferric citrate) long-term Phase 3 study results published in JASN 4
... evolutionary paradigm, Luiz Rocha and colleagues from the Smithsonian ... and the University of Hawaii, report coral reef fish ... than from fish thousands of miles away. An ecological ... development of a more synthetic treatment of speciation on ...
... the mouth and throat, surgery is a frequent ... swallowing dysfunction and external scarring. Researchers from the ... Otorhinolaryngology/Head and Neck Surgery, have completed two studies ... demonstrate the effective use of the daVinci Surgical ...
... of Medicine in St. Louis have learned that a ... successes in treating diabetic rats with embryonic pig tissues. ... surprised to find that they didn't have to give ... cell transplants. They had expected rats that received no ...
Cached Biology News:An (ecological) origin of species for tropical reef fish 2Penn Researchers Use Robotic Surgery 2Penn Researchers Use Robotic Surgery 3Precise Timing Enabled Pig-to-rat Transplants To Cure Diabetes 2Precise Timing Enabled Pig-to-rat Transplants To Cure Diabetes 3
... ESGRO Complete Derivation Kit is intended ... cells from delayed blastocysts in serum-free ... Clonal Grade ... Blastocyst Incubation Medium Trypsin Solution ...
AedestaTM Animal Organ/Tissue Perfusion Soln....
RAT ANTI MOUSE JAM-2 Immunogen: Recombinant soluble JAM-2...
casein kinase 2, alpha 1 polypeptide, transcript variant 2, mRNA (cDNA clone MGC:15232 IMAGE:4121882), complete cds...
Biology Products: